DE3884309D1 - Transdermales Abgabesystem für Procaterol. - Google Patents

Transdermales Abgabesystem für Procaterol.

Info

Publication number
DE3884309D1
DE3884309D1 DE88112375T DE3884309T DE3884309D1 DE 3884309 D1 DE3884309 D1 DE 3884309D1 DE 88112375 T DE88112375 T DE 88112375T DE 3884309 T DE3884309 T DE 3884309T DE 3884309 D1 DE3884309 D1 DE 3884309D1
Authority
DE
Germany
Prior art keywords
delivery system
transdermal delivery
procaterol
administration
bronchodilator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88112375T
Other languages
English (en)
Other versions
DE3884309T2 (de
Inventor
Niranjan M Patel
Mohan B Kabadi
Susan C Moniot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3884309D1 publication Critical patent/DE3884309D1/de
Publication of DE3884309T2 publication Critical patent/DE3884309T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE88112375T 1987-07-31 1988-07-29 Transdermales Abgabesystem für Procaterol. Expired - Fee Related DE3884309T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/079,965 US4788064A (en) 1987-07-31 1987-07-31 Transdermal delivery system

Publications (2)

Publication Number Publication Date
DE3884309D1 true DE3884309D1 (de) 1993-10-28
DE3884309T2 DE3884309T2 (de) 1994-01-20

Family

ID=22153943

Family Applications (1)

Application Number Title Priority Date Filing Date
DE88112375T Expired - Fee Related DE3884309T2 (de) 1987-07-31 1988-07-29 Transdermales Abgabesystem für Procaterol.

Country Status (7)

Country Link
US (1) US4788064A (de)
EP (1) EP0301589B1 (de)
JP (1) JPS6442432A (de)
AT (1) ATE94769T1 (de)
CA (1) CA1309661C (de)
DE (1) DE3884309T2 (de)
ES (1) ES2043744T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3844247A1 (de) * 1988-12-29 1990-07-12 Minnesota Mining & Mfg Vorrichtung, insbesondere pflaster zum transdermalen verabreichen eines medikaments
AU653156B2 (en) * 1990-06-14 1994-09-22 Dermamed Transdermal administration to humans and animals
GB2256588B (en) * 1990-11-09 1994-08-10 Teikoku Seiyaku Kk Preparation for transdermal administration of procaterol
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
IT1261849B (it) * 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
TW396350B (en) * 1996-12-04 2000-07-01 Nat Science Council Dielectric composition, slurry for use in the tape casting process, porcess for producing a ceramic product and process for preparing multilayer ceramic package
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
PE20081297A1 (es) 2003-04-30 2008-09-17 Purdue Pharma Lp Forma de dosificacion transdermica resistente a la manipulacion
US8790689B2 (en) 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
WO2011022371A2 (en) * 2009-08-17 2011-02-24 Silipos Inc. Gel product

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK109578A (da) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd Fremgangsmaade til fremstilling af heterocycliske forbindelser
JPS6045522B2 (ja) * 1982-12-08 1985-10-09 憲司 中村 化粧用具
FR2547502B1 (fr) * 1983-06-15 1986-05-16 Dexo Lab Pharma Matrice pour la diffusion continue et progressive d'un principe actif par voie transcutanee
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
ZA853488B (en) * 1984-05-10 1986-12-30 American Home Prod Transdermal dosage form
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4687481A (en) * 1984-10-01 1987-08-18 Biotek, Inc. Transdermal drug delivery system
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4690683A (en) * 1985-07-02 1987-09-01 Rutgers, The State University Of New Jersey Transdermal varapamil delivery device
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
ZA875317B (en) * 1986-08-01 1988-01-25 Warner-Lambert Company Transdermal compositions
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
JPH02503672A (ja) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル

Also Published As

Publication number Publication date
US4788064A (en) 1988-11-29
JPS6442432A (en) 1989-02-14
DE3884309T2 (de) 1994-01-20
EP0301589A2 (de) 1989-02-01
EP0301589A3 (en) 1989-07-12
ATE94769T1 (de) 1993-10-15
ES2043744T3 (es) 1994-01-01
EP0301589B1 (de) 1993-09-22
CA1309661C (en) 1992-11-03

Similar Documents

Publication Publication Date Title
DE68910159T2 (de) Dosierform für Verabreichung in der Humanmedizin.
DE3884309T2 (de) Transdermales Abgabesystem für Procaterol.
DE3669828D1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
DE3881340D1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
ATE5563T1 (de) Therapeutisches system zum zufuehren von arzneimitteln zur haut.
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
ATE71287T1 (de) Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
CA2064687A1 (en) Method and device for administering dexmedetomidine transdermaly
DE3769707D1 (de) Therapeutisches system mit geregelter wirkstoffabgabe.
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
ES2032905T3 (es) Sistema terapeutico transcutaneo.
DE68911499D1 (de) Topisch anzuwendende Zubereitungen und Systeme zur transdermalen Verabreichung enthaltend 1-Isobutyl-1H-imidazo[4,5-c]chinolin-4-amine.
DK324687A (da) Transdermalt farmeceutisk praeparat
KR870700373A (ko) 동전학적 의약투여 속도를 제어하는 시스텝 및 방법
ES2059312T3 (es) Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
DK79889A (da) Flerlagsplaster til transdermal laegemiddeladministration
EP0227531A3 (de) Pyroglutaminsäureester zur Verwendung als dermaler Penetrationsbeschleuniger für Arzneistoffe
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
DK408188D0 (da) Injicerbart middel til kontrolleret frigivelse af opioid-analgetika
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
ES284095Y (es) Disposicion de canulas perfeccionada para la administracion terapeutica de medicamentos.
DE3678729D1 (de) Neue arzneimittelzubereitung mit geregelter verabreichung des aktiven mittels, und deren herstellungsverfahren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee